What Did the 2027 Medicare Final Rule Change for Podiatry?
As of November 2026, the same-day E/M reduction is a Medicare payment policy, finalized in the CY 2027 Physician Fee Schedule on November 4, that pays 20% less for the lower-paid service when an office E/M visit billed with modifier 25 falls on the same day as a 0-day global procedure. It takes effect January 1, 2027, and APMA reports that CMS acknowledged the policy will disproportionately affect podiatry.
Smaller than proposed:
CMS cut the reduction from 50% to 20% and dropped 10-day and 90-day global procedures from the final policy.
Routine foot care is in scope:
Common 0-day podiatry codes such as nail debridement, corn and callus paring, and injections fall under the rule when billed with a same-day E/M.
It stacks on a lower conversion factor:
The 2027 non-APM conversion factor drops 2.31% to $32.63, so most podiatry claims pay less before the same-day reduction applies.
What CMS Finalized on November 4
One question we hear constantly from podiatry practice managers is whether the July proposal would survive the comment period. As of November 4, 2026, the answer is yes, in a smaller form.
CMS released the CY 2027 Physician Fee Schedule final rule on November 4, 2026 (Federal Register document 2026-22743), effective for services on or after January 1, 2027. According to the CMS fact sheet on the final rule, when a separately identifiable office or outpatient E/M visit is furnished by the same physician, or a physician in the same group practice, on the same day as a 0-day global procedure, the most expensive service is paid at 100% and the other services are paid at 80%. CMS made two major changes after public comments: it narrowed the policy to 0-day globals only, and it softened the reduction from 50% to 20%.
| Policy Element | July 2026 Proposal | November 2026 Final Rule |
|---|---|---|
| Global periods affected | 0-day, 10-day, and 90-day | 0-day only |
| Payment for the lower-paid service | 50% of the normal rate | 80% of the normal rate |
| Who it applies to | Same physician or same group practice | Same physician or same group practice |
| Non-APM conversion factor | $32.84 | $32.63 |
| Effective date | January 1, 2027, if finalized | January 1, 2027 |
CMS framed the change as ending duplicate payment for clinical work already built into a procedure’s valuation. As of November 2026, CMS has not yet published the claims processing instructions that show exactly how Medicare Administrative Contractors will apply the reduction on remittances, so watch for an MLN Matters article or change request before January. For background on what was originally proposed, see our breakdown of the proposed modifier 25 cut.
Which Podiatry Visits Does the 20% Same-Day Cut Apply To?
The 20% reduction applies when a podiatrist bills a separately identifiable office or outpatient E/M visit with modifier 25 on the same day as a procedure that carries a 0-day global period. Procedures with 10-day or 90-day global periods, such as matrixectomies and most foot surgeries, are excluded under the final rule.
| Common Podiatry Service | Example CPT | Global Period | Reduced With Same-Day E/M in 2027? |
|---|---|---|---|
| Nail debridement | 11720, 11721 | 0-day | Yes |
| Paring corns or calluses | 11055 to 11057 | 0-day | Yes |
| Tendon sheath or joint injection | 20550, 20600 | 0-day | Yes |
| Nail avulsion | 11730 | 0-day | Yes |
| Matrixectomy for ingrown nail | 11750 | 10-day | No |
| Most forefoot and rearfoot surgery | 28000 series | 90-day | No |
Routine foot care visits are where the policy lands hardest. A diabetic patient seen for new heel pain who also receives nail debridement is a textbook modifier 25 encounter, and in 2027 the lower-paid of those two services takes the 20% reduction. The same logic applies to an E/M paired with a CPT 20550 tendon sheath injection or with CPT 11721 nail debridement. Visits with an E/M and no procedure, and procedure-only visits billed without an E/M, are not affected by this policy. When a visit includes an E/M and more than one 0-day procedure, CMS pays the most expensive service at 100% and the other same-day services at 80%. As of November 2026, published guidance has not detailed how this interacts with existing multiple procedure payment rules, so confirm the logic with your MAC.
Why CMS Made the Change
CMS has argued for years that a procedure’s valuation already includes some evaluation work, so paying a full E/M on top of it duplicates payment. The agency first floated a similar reduction in the CY 2019 fee schedule proposal and did not finalize it then. In the CY 2027 rule, CMS also pointed to data showing that post-operative visits inside global periods often are not happening, and it paused the global surgery data collection required under MACRA section 523 while it decides how to revalue global packages.
The response from podiatry was immediate. On November 4, 2026, the American Podiatric Medical Association said the final cut will harm practices, noting that while 20% is less severe than the proposed 50%, solo, small, and rural practices are especially vulnerable to closure or consolidation. That framing matters for planning, because it signals continued advocacy rather than a settled issue. Practices should plan for the 20% reduction on January 1 while watching for any congressional or regulatory relief during 2027.
The rule also signals where Medicare is heading on E/M payment more broadly. CMS finalized a change that converts the G2211 complexity add-on code into modifier B1, which raises the associated E/M payment by 16%. Commercial payers set their own modifier 25 policies, and those policies can move in either direction, as the Regence modifier 25 reversal showed. Check each plan’s 2027 policy updates rather than assuming they mirror Medicare.
How Much Will the Same-Day Reduction Cost a Podiatry Practice?
The cost depends on how often your providers bill modifier 25 with a 0-day procedure. Each affected encounter loses 20% of the lower-paid service, and the 2.31% conversion factor cut lowers both services first. For a busy routine foot care practice, that combination can reach five figures a year in reduced Medicare payments.
Here is a simple illustration using assumed numbers, not actual fee schedule amounts. Assume a 2026 allowed amount of $100 for the E/M visit and $50 for same-day nail debridement, or $150 per encounter. In 2027, the conversion factor cut brings those to roughly $97.69 and $48.85. The debridement is the lower-paid service, so it is paid at 80%, or about $39.08. The encounter now pays about $136.77, a drop of roughly $13 per visit.
A practice that bills 25 of these encounters a week across 48 weeks would see about 1,200 affected visits and roughly $15,900 less in Medicare payments in 2027. Actual results will vary because RVUs change code by code and locality adjustments differ, but the math shows why the same-day policy deserves a line in every podiatry budget.
In our experience matching podiatry practices with billing partners, few practices know their modifier 25 rate offhand. The ones that do can model 2027 in an afternoon. The ones that do not usually discover the impact one remittance at a time in the first quarter.
What Should Podiatry Practices Do Before January 1, 2027?
The policy is final, but the claims it affects have not been billed yet. Use the remaining weeks of 2026 to prepare:
- Pull a 2026 report of every claim with modifier 25 and a same-day 0-day procedure to size your exposure.
- Rank those encounters by code pair, so you know which combinations, such as an E/M with 11721 or with 20550, drive most of the reduction.
- Audit E/M documentation to confirm each modifier 25 visit is significant and separately identifiable from the procedure.
- Update payment expectations in your practice management system so underpayment flags do not fire on correctly reduced 2027 claims.
- Re-forecast 2027 Medicare revenue using the $32.63 conversion factor and the 80% same-day rate.
- Review Medicare Advantage and commercial contracts that pay as a percentage of the Medicare fee schedule.
- Watch for CMS claims processing instructions and MAC bulletins before January 1, 2027.
Do not stop billing legitimate modifier 25 visits to avoid the reduction. An 80% payment on a documented, separately identifiable E/M is still revenue the practice earned, and under-coding creates its own compliance and revenue problem.
Practices often come to us after a fee schedule change exposes how little visibility they have into their own code mix. A billing partner that already tracks modifier 25 by code pair makes this preparation fast.
The 2027 same-day cut makes every podiatry E/M and procedure pairing worth checking.
Get matched with podiatry billing companies in our network that can model your exposure and keep 2027 claims clean.
Common Misreadings of the Final Rule
The final rule landed months after a widely covered proposal, so outdated assumptions are spreading. These are the misreadings we expect to cause the most billing mistakes in early 2027, along with what the final rule actually says about each one.
- The 50% cut is coming. It is not. The final rule pays the lower-paid service at 80%, a 20% reduction, not the 50% reduction CMS proposed in July 2026.
- Surgery days are affected. Procedures with 10-day and 90-day global periods were removed from the policy. An E/M billed with a matrixectomy or a bunion procedure is not subject to this reduction.
- Splitting the visit between providers avoids it. The policy applies to the same physician or a physician in the same group practice. Having one partner do the E/M and another do the procedure on the same day does not sidestep it, and APMA describes the scope as physicians of the same specialty in the same group.
- The E/M always takes the hit. The reduction falls on the lower-paid service. In most routine foot care visits that is the procedure, but in a visit with a higher-valued procedure it can be the E/M.
- G2211 disappears. The complexity add-on becomes modifier B1 in 2027, which adds 16% to the associated E/M. Practices that billed G2211 need to update their workflows, not drop the concept.
In-House vs. Outsourced Billing for 2027
Thinner margins make every denied or underpaid claim more expensive. With podiatry claim denials already rising in 2026, a 2.31% conversion factor cut and a same-day reduction leave less room for rework, missed appeals, and charge entry errors. An in-house biller juggling front desk duties may not have time to model code-pair exposure, reconcile reduced payments against the new rule, and catch MAC processing errors in the first months of 2027.
A specialized podiatry billing company should be able to show you your modifier 25 rate, flag reductions that were applied incorrectly, and keep documentation aligned with Medicare podiatry billing guidelines. Our team, including Tim Daniels, Director of Strategic Accounts at Billing Service Quotes, follows fee schedule changes like this one because they shape the questions podiatry practices bring to us every week. When you compare billing partners, ask how they will report modifier 25 volume by code pair, how they will verify that MACs apply the 80% rate only where it belongs, and how fast they appeal incorrect reductions.
Podiatry Bill Co connects practices with podiatry billing services from billing companies in our network, using a personalized matching process with human review. Billing Service Quotes, our parent platform, has connected more than 2,000 providers across all 50 states, with over 15 years in medical billing. Practices are typically connected with billing partners within 30 minutes, rates start as low as 2.95%, and matching is 100% free for providers.
Frequently Asked Questions
Yes. CMS finalized the policy in the CY 2027 Physician Fee Schedule final rule released on November 4, 2026. It reduces payment for the lower-paid service by 20% when an office E/M visit billed with modifier 25 occurs on the same day as a 0-day global procedure.
The reduction applies to services furnished on or after January 1, 2027. As of November 2026, CMS has not yet released the detailed claims processing instructions, so practices should watch for MLN Matters guidance and Medicare Administrative Contractor bulletins before the effective date.
No. CMS proposed including 0-day, 10-day, and 90-day global procedures, but the final rule limits the reduction to 0-day global procedures only. An E/M billed with a matrixectomy or a major foot surgery is not reduced under this policy.
The most expensive service is paid at 100%, and the other same-day service is paid at 80%. In most podiatry routine foot care visits the procedure is the lower-paid service, but the reduced service depends on the codes billed.
For 2027, the non-APM conversion factor is $32.63, down 2.31% from $33.40, and the qualifying APM conversion factor is $32.95, down 1.83% from $33.57. Most of the drop comes from the expiration of a one-year 2.5% increase Congress provided for 2026.
The final rule sets payment under the Medicare Physician Fee Schedule. Medicare Advantage and commercial plans follow their own contracts and policies, but plans that pay a percentage of the Medicare fee schedule may reflect the change. Review each contract and 2027 payer policy update.
Next Steps
- Want the background? Read our breakdown of the proposed modifier 25 cut and our earlier look at podiatry reimbursement in 2027.
- Billing nail care with an E/M? Review the CPT 11721 nail debridement guide before January.
- Tightening Medicare compliance? Start with our podiatry billing guidelines.
- Ready to protect 2027 revenue? Compare podiatry billing services from billing companies in our network.
Protect your 2027 Medicare revenue.
Get matched with podiatry billing companies in our network, free, with rates starting as low as 2.95%.